ADHD Rates Surge Among American Children
ADHD cases have risen at an alarming rate in the United States according to new data from the U.S. Centers for Disease Control and Prevention (CDC). As of 2022, one in nine children had been diagnosed with ADHD—an increase of 5.4 million diagnoses since 2016.1 2 ADHD is formally known as attention-deficit/hyperactivity disorder. Researchers analyzed […]
COVID Shots and Rise in Excess Deaths in Many Countries
A recent study published in the British medical journal The BMJ found a total of 3,089,465 “excess deaths” reported in 47 Western countries during the first three years of the COVID-19 pandemic—from Jan. 1, 2020 through Dec. 31, 2022. The study, conducted by researchers from Vrije Universiteit Amsterdam in the Netherlands, suggests that part of the […]
WHO Prequalifies Takeda’s Qdenga Dengue Vaccine
On May 10, 2024, the World Health Organization (WHO) granted prequalification status to the Qdenga (TAK-003) dengue vaccine, developed by Takeda Pharmaceutical Company Ltd. of Tokyo, Japan. The live attenuated virus vaccine is recommended to be given in two doses three months apart to children six to 16 years old living in areas where dengue […]
New mRNA Cancer “Vaccine” Targets Aggressive Brain Tumors
A new mRNA cancer biological labeled a “vaccine” is showing promise in treating an aggressive type of brain cancer called glioblastoma. The novel cancer-fighting biological, which was developed at the University of Florida, has successfully reprogrammed the immune systems of four adult glioblastoma patients’ to attack the malignant brain tumors, according to results of the […]
AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects
AstraZeneca plc, the largest and most profitable pharmaceutical company in the United Kindgdom1 has admitted in court documents that its COVID-19 vaccine, Vaxzevria, which was developed in partnership with the University of Oxford, can cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) in “very rare cases.” TTS is an immune disorder specifically associated with […]
Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines,1 has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States related to cancer risks associated with its over-the-counter heartburn drug Zantac (also known as ranitidine). The acid reflux drug was discontinued in […]
